First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

Autor: YuI Pryamikova, Gayane Tumyan, EA Osmanov, AA Leont’eva, LV Manzyuk, E A Demina, V. B. Larionova, O P Trofimova, NA Probatova, NV Kokosadze, V M Sotnikov, YuE Ryabukhina, NV Volkova, EV Paramonova, EG Medvedovskaya

Publikováno v: Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 443-452 (2017)

Aim. To assess the efficacy and toxicity of intensive 6 courses EACOPP-14 treatment with or without radiotherapy (RT) for advanced stages of Hodgkin's lymphoma (HL). Materials & Methods. From November 2009 to February 2015, 95 patients with advanced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c406459b1b244839194bb5b97f7446a0
http://bloodjournal.ru/wp-content/uploads/2017/10/3_1.pdf

Primary Extranodal Marginal Zone Lymphoma of the Renal Pelvis: A Case Report and Review of the Literature.

Autor: Volkova MI; Urological Department of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation., Gridneva YV; Urological Department of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation., Probatova NA; Department of Morphological and Molecular Genetic Diagnostics of Tumors of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation., Mochalnikova VV; Department of Morphological and Molecular Genetic Diagnostics of Tumors of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation., Turupaev KA; Urological Department of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation., Matveev VB; Urological Department of FSBI N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2022 Mar 31; Vol. 15 (1), pp. 362-368. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).

[The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].

Autor: Vasil'ev VI; Clinic MEDSI., Chal'tsev BD; Nasonova Research Institute of Rheumatology., Gorodetskii VR; Nasonova Research Institute of Rheumatology., Pal'shina SG; Nasonova Research Institute of Rheumatology., Shornikova NS; Nasonova Research Institute of Rheumatology., Anan'eva LP; Nasonova Research Institute of Rheumatology., Gaiduk IV; Yevdokimov Moscow State University of Medicine and Dentistry., Kokosadze NV; Blokhin National Medical Research Center of Oncology., Probatova NA; Blokhin National Medical Research Center of Oncology., Pavlovskaia AI; Blokhin National Medical Research Center of Oncology., Rodionova EB; Treatment Center., Safonova TN; Research Institute of Eye Diseases., Balabina AA; Sechenov First Moscow State Medical University (Sechenov University).

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2020 Dec 15; Vol. 92 (12), pp. 126-136. Date of Electronic Publication: 2020 Dec 15.

Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren's syndrome.

Autor: Gorodetskiy VR; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Probatova NA; Department of Pathology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Vasilyev VI; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.

Publikováno v: International journal of rheumatic diseases [Int J Rheum Dis] 2020 Apr; Vol. 23 (4), pp. 540-548. Date of Electronic Publication: 2020 Feb 25.

Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren's syndrome and rheumatoid arthritis: a case report.

Autor: Gorodetskiy VR; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Kashirskoye shosse 34А, Moscow, 115522, Russia. gorodetskiyblood@mail.ru., Probatova NA; Department of Pathology, N.N. Blokhin Russian Cancer Research Center, Kashirskoye shosse 24, Moscow, 115478, Russia., Konovalov DM; Department of Pathology, Dmitry Rogachev Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology, Leninsky Prospect, 117, Moscow, 117513, Russia., Ryzhikova NV; Laboratory of Molecular Hematology, National Hematology Research Center, Novy Zykovskiy Proezd, 4a, Moscow, 125167, Russia., Sidorova YV; Laboratory of Molecular Hematology, National Hematology Research Center, Novy Zykovskiy Proezd, 4a, Moscow, 125167, Russia., Sudarikov AB; Laboratory of Molecular Hematology, National Hematology Research Center, Novy Zykovskiy Proezd, 4a, Moscow, 125167, Russia., Mukhortova OV; Department of Nuclear Diagnostics, A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Roublyevskoe Shosse 135, Moscow, 121552, Russia.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2020 Jan 17; Vol. 14 (1), pp. 12. Date of Electronic Publication: 2020 Jan 17.